866-997-4948(US-Canada Toll Free)

Europe Axitinib Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 113 Pages

Notes:
Sales, means the sales volume of Axitinib
Revenue, means the sales value of Axitinib

This report studies sales (consumption) of Axitinib in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Axitinib in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on sales, market share and growth rate of Axitinib in each application, can be divided into
Application 1
Application 2

Table of Contents

Europe Axitinib Market Report 2017
1 Axitinib Overview
1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
1.2.1 Type I
1.2.2 Type II
1.3 Application of Axitinib
1.3.1 Application 1
1.3.2 Application 2
1.4 Axitinib Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Axitinib (2012-2022)
1.5.1 Europe Axitinib Sales and Growth Rate (2012-2022)
1.5.2 Europe Axitinib Revenue and Growth Rate (2012-2022)

2 Europe Axitinib by Manufacturers, Type and Application
2.1 Europe Axitinib Market Competition by Manufacturers
2.1.1 Europe Axitinib Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Axitinib Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Axitinib (Volume and Value) by Type
2.2.1 Europe Axitinib Sales and Market Share by Type (2012-2017)
2.2.2 Europe Axitinib Revenue and Market Share by Type (2012-2017)
2.3 Europe Axitinib (Volume and Value) by Countries
2.3.1 Europe Axitinib Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Axitinib Revenue and Market Share by Countries (2012-2017)
2.4 Europe Axitinib (Volume) by Application

3 Germany Axitinib (Volume, Value and Sales Price)
3.1 Germany Axitinib Sales and Value (2012-2017)
3.1.1 Germany Axitinib Sales and Growth Rate (2012-2017)
3.1.2 Germany Axitinib Revenue and Growth Rate (2012-2017)
3.1.3 Germany Axitinib Sales Price Trend (2012-2017)
3.2 Germany Axitinib Sales and Market Share by Manufacturers
3.3 Germany Axitinib Sales and Market Share by Type
3.4 Germany Axitinib Sales and Market Share by Application

4 France Axitinib (Volume, Value and Sales Price)
4.1 France Axitinib Sales and Value (2012-2017)
4.1.1 France Axitinib Sales and Growth Rate (2012-2017)
4.1.2 France Axitinib Revenue and Growth Rate (2012-2017)
4.1.4 France Axitinib Sales Price Trend (2012-2017)
4.2 France Axitinib Sales and Market Share by Manufacturers
4.3 France Axitinib Sales and Market Share by Type
4.4 France Axitinib Sales and Market Share by Application

5 UK Axitinib (Volume, Value and Sales Price)
5.1 UK Axitinib Sales and Value (2012-2017)
5.1.1 UK Axitinib Sales and Growth Rate (2012-2017)
5.1.2 UK Axitinib Revenue and Growth Rate (2012-2017)
5.1.5 UK Axitinib Sales Price Trend (2012-2017)
5.2 UK Axitinib Sales and Market Share by Manufacturers
5.3 UK Axitinib Sales and Market Share by Type
5.4 UK Axitinib Sales and Market Share by Application

6 Russia Axitinib (Volume, Value and Sales Price)
6.1 Russia Axitinib Sales and Value (2012-2017)
6.1.1 Russia Axitinib Sales and Growth Rate (2012-2017)
6.1.2 Russia Axitinib Revenue and Growth Rate (2012-2017)
6.1.6 Russia Axitinib Sales Price Trend (2012-2017)
6.2 Russia Axitinib Sales and Market Share by Manufacturers
6.3 Russia Axitinib Sales and Market Share by Type
6.4 Russia Axitinib Sales and Market Share by Application

7 Italy Axitinib (Volume, Value and Sales Price)
7.1 Italy Axitinib Sales and Value (2012-2017)
7.1.1 Italy Axitinib Sales and Growth Rate (2012-2017)
7.1.2 Italy Axitinib Revenue and Growth Rate (2012-2017)
7.1.7 Italy Axitinib Sales Price Trend (2012-2017)
7.2 Italy Axitinib Sales and Market Share by Manufacturers
7.3 Italy Axitinib Sales and Market Share by Type
7.4 Italy Axitinib Sales and Market Share by Application

8 Spain Axitinib (Volume, Value and Sales Price)
8.1 Spain Axitinib Sales and Value (2012-2017)
8.1.1 Spain Axitinib Sales and Growth Rate (2012-2017)
8.1.2 Spain Axitinib Revenue and Growth Rate (2012-2017)
8.1.8 Spain Axitinib Sales Price Trend (2012-2017)
8.2 Spain Axitinib Sales and Market Share by Manufacturers
8.3 Spain Axitinib Sales and Market Share by Type
8.4 Spain Axitinib Sales and Market Share by Application

9 Benelux Axitinib (Volume, Value and Sales Price)
9.1 Benelux Axitinib Sales and Value (2012-2017)
9.1.1 Benelux Axitinib Sales and Growth Rate (2012-2017)
9.1.2 Benelux Axitinib Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Axitinib Sales Price Trend (2012-2017)
9.2 Benelux Axitinib Sales and Market Share by Manufacturers
9.3 Benelux Axitinib Sales and Market Share by Type
9.4 Benelux Axitinib Sales and Market Share by Application

10 Europe Axitinib Manufacturers Analysis
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Axitinib Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Allergan
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Axitinib Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Alnylam Pharmaceuticals
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Axitinib Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Amgen
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Axitinib Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Angstrom Pharmaceuticals
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Axitinib Product Type, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Acceleron Pharma
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Axitinib Product Type, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Biocon
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Axitinib Product Type, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Bionomics
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Axitinib Product Type, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 CASI Pharmaceuticals
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Axitinib Product Type, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Celgene Corporation
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Axitinib Product Type, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Enzon Pharmaceuticals
10.12 Five Prime Therapeutics
10.13 Fujifilm Kyowa Kirin Biologics
10.14 Genentech

11 Axitinib Manufacturing Cost Analysis
11.1 Axitinib Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Axitinib

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Axitinib Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Axitinib Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Axitinib Market Forecast (2017-2022)
14.1 Germany Axitinib Sales Forecast (2017-2022)
14.2 France Axitinib Sales Forecast (2017-2022)
14.3 UK Axitinib Sales Forecast (2017-2022)
14.4 Russia Axitinib Sales Forecast (2017-2022)
14.5 Italy Axitinib Sales Forecast (2017-2022)
14.6 Spain Axitinib Sales Forecast (2017-2022)
14.7 Benelux Axitinib Sales Forecast (2017-2022)
14.8 Europe Axitinib Sales Forecast by Type (2017-2022)
14.9 Europe Axitinib Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Axitinib
Table Classification of Axitinib
Figure Europe Sales Market Share of Axitinib by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Axitinib
Figure Europe Sales Market Share of Axitinib by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Axitinib Revenue and Growth Rate (2012-2022)
Figure France Axitinib Revenue and Growth Rate (2012-2022)
Figure UK Axitinib Revenue and Growth Rate (2012-2022)
Figure Russia Axitinib Revenue and Growth Rate (2012-2022)
Figure Italy Axitinib Revenue and Growth Rate (2012-2022)
Figure Spain Axitinib Revenue and Growth Rate (2012-2022)
Figure Benelux Axitinib Revenue and Growth Rate (2012-2022)
Figure Europe Axitinib Sales and Growth Rate (2012-2022)
Figure Europe Axitinib Revenue and Growth Rate (2012-2022)
Table Europe Axitinib Sales of Key Manufacturers (2015 and 2016)
Table Europe Axitinib Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Axitinib Sales Share by Manufacturers
Figure 2016 Axitinib Sales Share by Manufacturers
Table Europe Axitinib Revenue by Manufacturers (2015 and 2016)
Table Europe Axitinib Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Axitinib Revenue Share by Manufacturers
Table 2016 Europe Axitinib Revenue Share by Manufacturers
Table Europe Axitinib Sales and Market Share by Type (2012-2017)
Table Europe Axitinib Sales Share by Type (2012-2017)
Figure Sales Market Share of Axitinib by Type (2012-2017)
Figure Europe Axitinib Sales Growth Rate by Type (2012-2017)
Table Europe Axitinib Revenue and Market Share by Type (2012-2017)
Table Europe Axitinib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Axitinib by Type (2012-2017)
Figure Europe Axitinib Revenue Growth Rate by Type (2012-2017)
Table Europe Axitinib Sales and Market Share by Countries (2012-2017)
Table Europe Axitinib Sales Share by Countries (2012-2017)
Figure Sales Market Share of Axitinib by Countries (2012-2017)
Table Europe Axitinib Revenue and Market Share by Countries (2012-2017)
Table Europe Axitinib Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Axitinib by Countries (2012-2017)
Table Europe Axitinib Sales and Market Share by Application (2012-2017)
Table Europe Axitinib Sales Share by Application (2012-2017)
Figure Sales Market Share of Axitinib by Application (2012-2017)
Figure Germany Axitinib Sales and Growth Rate (2012-2017)
Figure Germany Axitinib Revenue and Growth Rate (2012-2017)
Figure Germany Axitinib Sales Price Trend (2012-2017)
Table Germany Axitinib Sales by Manufacturers (2015 and 2016)
Table Germany Axitinib Market Share by Manufacturers (2015 and 2016)
Table Germany Axitinib Sales by Type (2015 and 2016)
Table Germany Axitinib Market Share by Type (2015 and 2016)
Table Germany Axitinib Sales by Application (2015 and 2016)
Table Germany Axitinib Market Share by Application (2015 and 2016)
Figure France Axitinib Sales and Growth Rate (2012-2017)
Figure France Axitinib Revenue and Growth Rate (2012-2017)
Figure France Axitinib Sales Price Trend (2012-2017)
Table France Axitinib Sales by Manufacturers (2015 and 2016)
Table France Axitinib Market Share by Manufacturers (2015 and 2016)
Table France Axitinib Sales by Type (2015 and 2016)
Table France Axitinib Market Share by Type (2015 and 2016)
Table France Axitinib Sales by Application (2015 and 2016)
Table France Axitinib Market Share by Application (2015 and 2016)
Figure UK Axitinib Sales and Growth Rate (2012-2017)
Figure UK Axitinib Revenue and Growth Rate (2012-2017)
Figure UK Axitinib Sales Price Trend (2012-2017)
Table UK Axitinib Sales by Manufacturers (2015 and 2016)
Table UK Axitinib Market Share by Manufacturers (2015 and 2016)
Table UK Axitinib Sales by Type (2015 and 2016)
Table UK Axitinib Market Share by Type (2015 and 2016)
Table UK Axitinib Sales by Application (2015 and 2016)
Table UK Axitinib Market Share by Application (2015 and 2016)
Figure Russia Axitinib Sales and Growth Rate (2012-2017)
Figure Russia Axitinib Revenue and Growth Rate (2012-2017)
Figure Russia Axitinib Sales Price Trend (2012-2017)
Table Russia Axitinib Sales by Manufacturers (2015 and 2016)
Table Russia Axitinib Market Share by Manufacturers (2015 and 2016)
Table Russia Axitinib Sales by Type (2015 and 2016)
Table Russia Axitinib Market Share by Type (2015 and 2016)
Table Russia Axitinib Sales by Application (2015 and 2016)
Table Russia Axitinib Market Share by Application (2015 and 2016)
Figure Italy Axitinib Sales and Growth Rate (2012-2017)
Figure Italy Axitinib Revenue and Growth Rate (2012-2017)
Figure Italy Axitinib Sales Price Trend (2012-2017)
Table Italy Axitinib Sales by Manufacturers (2015 and 2016)
Table Italy Axitinib Market Share by Manufacturers (2015 and 2016)
Table Italy Axitinib Sales by Type (2015 and 2016)
Table Italy Axitinib Market Share by Type (2015 and 2016)
Table Italy Axitinib Sales by Application (2015 and 2016)
Table Italy Axitinib Market Share by Application (2015 and 2016)
Figure Spain Axitinib Sales and Growth Rate (2012-2017)
Figure Spain Axitinib Revenue and Growth Rate (2012-2017)
Figure Spain Axitinib Sales Price Trend (2012-2017)
Table Spain Axitinib Sales by Manufacturers (2015 and 2016)
Table Spain Axitinib Market Share by Manufacturers (2015 and 2016)
Table Spain Axitinib Sales by Type (2015 and 2016)
Table Spain Axitinib Market Share by Type (2015 and 2016)
Table Spain Axitinib Sales by Application (2015 and 2016)
Table Spain Axitinib Market Share by Application (2015 and 2016)
Figure Benelux Axitinib Sales and Growth Rate (2012-2017)
Figure Benelux Axitinib Revenue and Growth Rate (2012-2017)
Figure Benelux Axitinib Sales Price Trend (2012-2017)
Table Benelux Axitinib Sales by Manufacturers (2015 and 2016)
Table Benelux Axitinib Market Share by Manufacturers (2015 and 2016)
Table Benelux Axitinib Sales by Type (2015 and 2016)
Table Benelux Axitinib Market Share by Type (2015 and 2016)
Table Benelux Axitinib Sales by Application (2015 and 2016)
Table Benelux Axitinib Market Share by Application (2015 and 2016)
Table Axitinib Basic Information List
Table Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Axitinib Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Axitinib Sales Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Axitinib Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Axitinib Sales Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Angstrom Pharmaceuticals Axitinib Sales Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Axitinib Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Axitinib Sales Market Share (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bionomics Axitinib Sales Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table CASI Pharmaceuticals Axitinib Sales Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Celgene Corporation Axitinib Sales Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information List
Table Five Prime Therapeutics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Genentech Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Axitinib
Figure Manufacturing Process Analysis of Axitinib
Figure Axitinib Industrial Chain Analysis
Table Raw Materials Sources of Axitinib Major Manufacturers in 2015
Table Major Buyers of Axitinib
Table Distributors/Traders List
Figure Germany Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Germany Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure France Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure France Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure UK Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure UK Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Russia Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Italy Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Spain Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Axitinib Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Axitinib Revenue and Growth Rate Forecast (2017-2022)
Table Europe Axitinib Sales Forecast by Type (2017-2022)
Table Europe Axitinib Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *